🇺🇸 Durlaza™ in United States

FDA authorised Durlaza™ on 4 September 2015

Marketing authorisation

FDA — authorised 4 September 2015

  • Application: NDA200671
  • Marketing authorisation holder: HESP
  • Local brand name: DURLAZA
  • Indication: CAPSULE, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is Durlaza™ approved in United States?

Yes. FDA authorised it on 4 September 2015.

Who is the marketing authorisation holder for Durlaza™ in United States?

HESP holds the US marketing authorisation.